These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23919628)
1. Eosinophils are not required for the induction and maintenance of an alloantibody response. Cravedi P; Lessman DA; Heeger PS Am J Transplant; 2013 Oct; 13(10):2696-702. PubMed ID: 23919628 [TBL] [Abstract][Full Text] [Related]
3. A case for APRIL/BLyS directed therapy not eosinophil directed therapy for alloantibody elimination. Redfield RR; Abt PL; Naji A Am J Transplant; 2014 Feb; 14(2):492-3. PubMed ID: 24320568 [No Abstract] [Full Text] [Related]
4. Eosinophil-targeted therapy: not the panacea for antibody-mediated rejection? Kers J; Florquin S Am J Transplant; 2013 Oct; 13(10):2522-3. PubMed ID: 23919601 [No Abstract] [Full Text] [Related]
5. The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients. Sicard A; Phares TW; Yu H; Fan R; Baldwin WM; Fairchild RL; Valujskikh A Am J Transplant; 2012 Jul; 12(7):1708-19. PubMed ID: 22420367 [TBL] [Abstract][Full Text] [Related]
6. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique. Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536 [TBL] [Abstract][Full Text] [Related]
7. No strict requirement for eosinophils for bone marrow plasma cell survival. Bortnick A; Chernova I; Spencer SP; Allman D Eur J Immunol; 2018 May; 48(5):815-821. PubMed ID: 29442367 [TBL] [Abstract][Full Text] [Related]
8. Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice. Redfield RR; Lou Y; Rodriguez E; Rostami S; Parsons RF; Noorchashm H; Naji A; Abt PL Transpl Immunol; 2013 Dec; 29(1-4):11-6. PubMed ID: 24103731 [TBL] [Abstract][Full Text] [Related]
9. Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow. Haberland K; Ackermann JA; Ipseiz N; Culemann S; Pracht K; Englbrecht M; Jäck HM; Schett G; Schuh W; Krönke G Eur J Immunol; 2018 May; 48(5):822-828. PubMed ID: 29442374 [TBL] [Abstract][Full Text] [Related]
10. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts. Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy. Gareau AJ; Nashan B; Hirsch GM; Lee TD J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675 [TBL] [Abstract][Full Text] [Related]
13. Fractionation of mature eosinophils in GATA-reporter transgenic mice. Kim K; Suzuki N; Ohneda K; Minegishi N; Yamamoto M Tohoku J Exp Med; 2010 Feb; 220(2):127-38. PubMed ID: 20139664 [TBL] [Abstract][Full Text] [Related]
14. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants. Shatry AM; Jones M; Levy RB Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693 [TBL] [Abstract][Full Text] [Related]
15. Allospecific Memory B Cell Responses Are Dependent on Autophagy. Fribourg M; Ni J; Nina Papavasiliou F; Yue Z; Heeger PS; Leventhal JS Am J Transplant; 2018 Jan; 18(1):102-112. PubMed ID: 28621910 [TBL] [Abstract][Full Text] [Related]
16. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection. Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624 [TBL] [Abstract][Full Text] [Related]
17. Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. Dyer KD; Czapiga M; Foster B; Foster PS; Kang EM; Lappas CM; Moser JM; Naumann N; Percopo CM; Siegel SJ; Swartz JM; Ting-De Ravin S; Rosenberg HF J Immunol; 2007 Aug; 179(3):1693-9. PubMed ID: 17641035 [TBL] [Abstract][Full Text] [Related]
19. Ibrutinib suppresses alloantibody responses in a mouse model of allosensitization. Kim I; Wu G; Chai NN; Klein AS; Jordan S Transpl Immunol; 2017 Dec; 45():59-64. PubMed ID: 28951258 [TBL] [Abstract][Full Text] [Related]